StockData
Ocular Therapeutix, Inc logo

Ocular Therapeutix, Inc (OCUL) stock

OCULNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3011% above fair value
$6.02+0.01 (+0.17%)

Close on Nov 17, 2026Market cap $1.32BP/E –Yield –

Ocular Therapeutix market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ocular Therapeutix's market cap was $1.46B on Nov 11, 2026, against $2.13B a year earlier. Over the last 5 years it ranged from $196.94M to $2.30B, with a median of $1.13B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.46B-31.1%
2025Dec 31, 2025$2.12B+58.8%
2024Dec 31, 2024$1.34B+277.7%
2023Dec 29, 2023$354.18M+63.7%
2022Dec 30, 2022$216.40M-59.5%
2021Dec 31, 2021$533.95M-59.1%
2020Dec 31, 2020$1.31B+587.5%
2019Dec 31, 2019$189.91M+17.7%
2018Dec 31, 2018$161.29M+23.3%
2017Dec 29, 2017$130.78M-37.2%
2016Dec 30, 2016$208.24M-10.1%
2015Dec 31, 2015$231.72M-53.8%
2014Dec 31, 2014$501.50M–

More Ocular Therapeutix figures

See a number that looks wrong?